Epigenetic Regulation of Cancer - Part A

Erscheinungsjahr 2023
ISBN: 978-0-443-22178-1
Verlag: Elsevier Science & Technology

Buch, Englisch, Format (B × H): 152 mm x 229 mm, Gewicht: 450 g

Epigenetic Regulation of Cancer - Part A, Volume 380 in the International Review of Cell and Molecular Biology series, presents content from various experts in epigenetics who cover multiple facets of cancer-associated epigenetic alterations, including the impact of epigenetic deregulation in all steps of oncogenesis as well as promising strategies to therapeutically target cancer-associated epigenetic deregulation. Specific chapters cover Epigenetic regulation of epithelial-mesenchymal transition during cancer development, Novel insights into DNA methylation-based epigenetic regulation of breast tumor angiogenesis, Super-enhancer landscape rewiring in cancer: The epigenetic control at distal sites, Non-coding RNAs in the epigenetic landscape of Cutaneous T-cell lymphoma, and much more.

Autoren/Hrsg.

Weitere Mitwirkende

Spada, Sheila

Fachgebiete

• Naturwissenschaften Biowissenschaften Zellbiologie
• Naturwissenschaften Biowissenschaften Molekularbiologie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung

Inhaltsverzeichnis

1. Epigenetic regulation of epithelial-mesenchymal transition during cancer development Sunisa Yoodee and Visith Thongboonkerd 2. Novel insights into DNA methylation-based epigenetic regulation of breast tumor angiogenesis Sharath Mohan Bhat, Palla Ranga Prasad, and Manjunath B. Joshi 3. Super-enhancer landscape rewiring in cancer: The epigenetic control at distal sites Eros Di Giorgio, Roberta Benetti, Emanuela Kerschbamer, Luigi Xodo, and Claudio Brancolini 4. Non-coding RNAs in the epigenetic landscape of Cutaneous T-cell lymphoma Monaza Adeeb, Lubna Therachiyil, Safwan Moton, Joerg Buddenkotte, Majid Ali Alam, Shahab Uddin, Martin Steinhoff, Aamir Ahmad 5. Epigenetic mechanism of therapeutic resistance and potential of epigenetic therapeutics in chemorefractory prostate cancer Priti Roy, and Kamaleshwar P. Singh 6. Epigenetic inhibitors and their role in cancer therapy Nouha Abdelaziz, Lubna Therachiyil, Hana Sadida, Ateeque M. Ali, Omar S. Khan, Mayank Singh, Abdul Q Khan, Ammira Al-Shabeeb Akil, Ajaz A. Bhat, Shahab Uddin

Über Autor(innen)

Spada, Sheila
Sheila Spada is at Weill Cornell Medical College, NY, USA